分析测试百科网

搜索

喜欢作者

微信支付微信支付
×

In Vitro T Cell Activation

2019.4.28
头像

zhaochenxu

致力于为分析测试行业奉献终身

In Vitro T Cell Activation

Introduction

Mature T cells recognize and respond to the antigen/MHC complex through their antigen-specific receptors (TCR). The most immediate consequence of TCR activation is the initiation of signaling pathways including induction of specific protein tyrosine kinases (PTKs), breakdown of phosphatidylinositol 4,5-biophosphate (PIP2), activation of protein kinase C (PKC) and elevation of intracellular calcium ion concentration. These early events are transmitted to the nucleus and result in

  1. clonal expansion of T cells,

  2. upregulation of activation markers on the cell surface,

  3. differentiation into effector cells,

  4. induction of cytotoxicity or cytokine secretion, and

  5. induction of apoptosis.

One of the most common ways to assess T cell activation is to measure T cell proliferation upon in vitro stimulation of T cells via antigen or agonistic antibodies to TCR.

This protocol is written as a starting point for examining in vitro proliferation of mouse splenic T-cells and human peripheral T cells stimulated via CD3. All steps where optimization by the user can be achieved for meaningful results have been highlighted. Briefly, these include titration of the cell concentration used, titration of the activating reagents and the optimal culture period for the best activation response.

Protocol A: Stimulation of mouse peripheral T cells with plate-bound 145-2C11 monoclonal antibody; MTT assay for detection of cellular proliferation.

What You Need

Materials

Instruments

Experiment Duration

Method

Antibody Coating of the Assay Plate

  1. Prepare a 5-10 µg/ml solution of anti-CD3e (145-2C11) in sterile PBS. Calculate the number of wells required for each experimental condition and consider triplicate samples for each condition. For example, to coat one-half plate (48 wells) 2.6 ml of antibody solution is required.
    Note: We have performed titration studies and found these concentrations of 145-2C11 to induce a maximal response. However, a pilot experiment to determine efficacy of other concentrations of this antibody to induce cellular activation can be performed. For co-stimulation studies using antibodies to other antigens, a suboptimal activation with anti-CD3 may be required. To achieve suboptimal activation via anti-CD3, a 0.5-0.1 µg/ml 145-2C11 antibody solution can be used.

  2. Dispense 50 µl of the antibody solution in each well of the 96-well assay plate. For the control unstimulated wells, add 50 µl of sterile PBS.

  3. Tightly cover the plate with Parafilm to avoid sample evaporation and incubate at 37°C for 2 hours or alternatively prepare the plate one day in advance and keep at 4°C overnight.

  4. Just before adding cells, remove the 50 µl antibody solution with a multichannel pipettor.

  5. Rinse each well with 200 µl of sterile PBS and discard PBS.

  6. Repeat step 5 to remove all unbound antibody from each well.

Addition of Cells

  1. Harvest spleen and prepare a single cell suspension under sterile condition. Follow the red cell lysis protocol to remove red cells. <click here> for RBC lysis protocol.

  2. Count cells and resuspend in complete RPMI-1640 at 106/ml.
    Note: This concentration of spleen cells gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.

  3. After washing the wells with PBS (step 6 above), add 200 µl of the cell suspension to each well and place in a humidified 37°C, 5% CO2 incubator.
    Note: For an additional stimulation control, incubate cells in 3 wells with Concanavalin A at 1-4 µg ConA per ml of culture medium.

  4. Incubate for 2-4 days.
    Note: Proliferation of cells between days 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.

  5. Add 20 µl of the MTT buffer to each well and put back in the incubator for 4 hours.

  6. Add 50 µl of the MTT Lysis Solution to each well, vortex gently and incubate overnight

  7. Read the plate at 570 nm the next day.

  8. Calculate the mean and standard errors and graph the data.

Protocol B: Stimulation of human peripheral blood mononuclear cells with anti-human CD3 monoclonal antibody; MTT assay for detection of cellular proliferation.

Human PBMCs can be activated in vitro by soluble anti-human CD3 antibodies. We have performed titration studies with these antibodies and established the following protocol for stimulation of PBMC.

What You Need

Materials

Instruments

Experiment Duration

Method

  1. Prepare PBMC and resuspend the cells at 1-2 x 106/ml of supplemented RPMI.
    Note: This concentration of PBMC gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.

  2. Add 100 µl of the cell suspension to each well. For each condition, use triplicate wells.

  3. Add soluble antibody in 100 µl to each well. Titrate antibodies for optimal performance in the assay conditions used. If isolated T cells are to be used in proliferation assays, we recommend using these antibodies at 10 µg/ml immobilized on plastic (i.e. bound to wells of 96-well assay plates).

  4. Place in a humidified 37°C, 5% CO2 incubator.

  5. Incubate for 2-4 days.
    Note: Proliferation of cells between day 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.

  6. Add 20 µl of the MTT buffer to each well and put back in the incubator for 4 hours.

  7. Add 50 µl of the MTT Lysis Solution to each well, vortex gently and incubate overnight.

  8. Read the plate at 570 nm the next day.

  9. Calculate the mean and standard errors and graph the data.

Buffers & Media

Supplemented RPMI-1640

MTT Buffer

MTT Lysing Solution


生物在线
仪器推荐
文章推荐